ASX - By Stock
|
HYD |
Re:
Ann: Half Year Results and Trading Update
|
|
harvett
|
3 |
1.4K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
86
|
26K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
86
|
26K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
5 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
86
|
26K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
0 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
86
|
26K
|
0
|
|
ASX - By Stock
|
HYD |
Re:
Action?
|
|
harvett
|
7 |
3.1K |
0 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
HYD |
Action?
|
|
harvett
|
7 |
3.1K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
7
|
3.1K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
0 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
86
|
26K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
News: KZA Kazia Therapeutics Ltd- Announces $2 Million Registered Direct Offering
|
|
harvett
|
9 |
3.1K |
3 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
9
|
3.1K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
86
|
26K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
0 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
86
|
26K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
harvett
|
86 |
26K |
1 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
86
|
26K
|
1
|
|
International Markets
|
|
Re:
Kazia
|
|
harvett
|
12 |
2.9K |
0 |
20/11/23 |
20/11/23 |
International Markets
|
12
|
2.9K
|
0
|
|
International Markets
|
|
Re:
Kazia
|
|
harvett
|
12 |
2.9K |
1 |
19/11/23 |
19/11/23 |
International Markets
|
12
|
2.9K
|
1
|
|
International Markets
|
|
Re:
Kazia
|
|
harvett
|
12 |
2.9K |
2 |
17/11/23 |
17/11/23 |
International Markets
|
12
|
2.9K
|
2
|
|
International Markets
|
|
Re:
Kazia
|
|
harvett
|
12 |
2.9K |
0 |
17/11/23 |
17/11/23 |
International Markets
|
12
|
2.9K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
harvett
|
21 |
6.3K |
7 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
21
|
6.3K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
harvett
|
21 |
6.3K |
4 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
21
|
6.3K
|
4
|
|
International Markets
|
|
Kazia
|
|
harvett
|
12 |
2.9K |
3 |
16/11/23 |
16/11/23 |
International Markets
|
12
|
2.9K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
harvett
|
71 |
18K |
0 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
71
|
18K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Excellent interim DIPG data from PNOC
|
|
harvett
|
21 |
6.3K |
2 |
12/11/23 |
12/11/23 |
ASX - By Stock
|
21
|
6.3K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
harvett
|
71 |
18K |
4 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
71
|
18K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Option 2 vs 3
|
|
harvett
|
71 |
18K |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
71
|
18K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
harvett
|
54 |
17K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
54
|
17K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
harvett
|
54 |
17K |
2 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
54
|
17K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
harvett
|
54 |
17K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
54
|
17K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
harvett
|
54 |
17K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
54
|
17K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
harvett
|
30 |
9.5K |
13 |
08/10/23 |
08/10/23 |
ASX - By Stock
|
30
|
9.5K
|
13
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
harvett
|
30 |
9.5K |
18 |
07/10/23 |
07/10/23 |
ASX - By Stock
|
30
|
9.5K
|
18
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Acceptance of late-breaking abstract of PNOC022 data
|
|
harvett
|
7 |
2.2K |
3 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
7
|
2.2K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
harvett
|
2.0K |
614K |
3 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
2.0K
|
614K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
harvett
|
2.0K |
614K |
5 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
2.0K
|
614K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: 2023 Corporate Governance Statement
|
|
harvett
|
22 |
6.2K |
5 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
22
|
6.2K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
harvett
|
273 |
88K |
5 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
273
|
88K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
harvett
|
273 |
88K |
4 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
273
|
88K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
harvett
|
103 |
38K |
5 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
103
|
38K
|
5
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Investor Presentation
|
|
harvett
|
2 |
1.4K |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
2
|
1.4K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
harvett
|
10 |
2.9K |
5 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
10
|
2.9K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
harvett
|
10 |
2.9K |
3 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
10
|
2.9K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
harvett
|
10 |
2.9K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
10
|
2.9K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
harvett
|
42 |
12K |
8 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
42
|
12K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
harvett
|
42 |
12K |
6 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
42
|
12K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
DIPG Panel Discussion
|
|
harvett
|
103 |
38K |
6 |
17/07/23 |
17/07/23 |
ASX - By Stock
|
103
|
38K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
harvett
|
42 |
12K |
9 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
42
|
12K
|
9
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Paxalisib receives Fast Track Designation from US FDA
|
|
harvett
|
42 |
12K |
7 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
42
|
12K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
KZA Media Thread
|
|
harvett
|
2.0K |
614K |
6 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
2.0K
|
614K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Corporate Update and Corporate Presentation
|
|
harvett
|
27 |
7.7K |
5 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
27
|
7.7K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
harvett
|
23 |
6.8K |
1 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
23
|
6.8K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Chief Executive Officer and Managing Director Appointment
|
|
harvett
|
107 |
27K |
1 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
107
|
27K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
harvett
|
34 |
11K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|